5-Amino-1MQ

Certificate of Analysis & Complete Test Results

✓ Verified & Certified
Test Date
Jan 30, 2026
Batch Number
114411
Purity Level
97.82%

Certificate of Analysis

High-Performance Liquid Chromatography

Client: Peptides Canada
Sample Name: Retatrutide
Batch #: 114411
Report Date: 4/11/2025
Test: Purity
Receipt Date: 4/09/2025
Analysis Date: 4/11/2025
Matrix: Powder
Number of samples: 1
Purity: 97.82%

Research-grade specification: ≥95.0% — this batch exceeds specification.

Date File 114411_MS2_posneg_Retatrutide_Triple_Agonist_Lot114411_purity.d Sample Name Retatrutide_Lot114411__purity
Sample Type Sample Position P9-25
Instrument Name LCMS-7800 Series Username -
Acq Method Retatrutide_Triple_Agonist_purity_145.m Acquired 04/11/2025 10:32:15 AM
IRM Calibration Status Calibrated Time (UTC-07:00)
Comment Sample test for purity of Retatrutide Triple Agonist batch 114411 DA Method SignalToNoiseCheckout.m
Sample Group Test Batch 8 Info. -
Stream Name LC1 Acquisition 04/11/2025 10:32:15 AM
Acquisition SW Version 6400 Series Triple Quadrupole B.09.00 (89037.0) Time (Local) (UTC-07:00)

Peak List

Time Area % Area
13.45 min 2187.3 97.82 %
16.12 min 48.7 2.18 %

* determined as Retatrutide based on retention time

Note: Percent area between two compounds is not quantitative due to variable extinction coefficients.

Test Screen

UV Chromatogram:

Identity: Retatrutide

(Other names: LY3437943, GGG Tri-agonist, Triple incretin receptor agonist)

CAS: 2381089-83-2

PMID: 37364589

Data

Mass Spectrum

MSMS ID — head to tail database matching

Mass Spectrum Protein Envelope encompasses the 3-6 positive change states conferring Peptide Mass

Retatrutide

Expected Mass: 4872.5

Observed Mass: 4872.4

Multiple Charge States:

  • [M+4H]4+:1250.2
  • [M+5H]5+:1000.3
  • [M+6H]6+:833.8
Reviewed and approved by:

Herman Lelie